Literature DB >> 25900819

Computationally simple analysis of matched, outcome-based studies of ordinal disease states.

Rebecca A Betensky1,2, Jackie Szymonifka2, Eudocia Q Lee3, Catherine L Nutt4, Tracy T Batchelor5.   

Abstract

Outcome-based sampling is an efficient study design for rare conditions, such as glioblastoma. It is often used in conjunction with matching, for increased efficiency and to potentially avoid bias due to confounding. A study was conducted at the Massachusetts General Hospital that involved retrospective sampling of glioblastoma patients with respect to multiple-ordered disease states, as defined by three categories of overall survival time. To analyze such studies, we posit an adjacent categories logit model and exploit its allowance for prospective analysis of a retrospectively sampled study and its advantageous removal of set and level specific nuisance parameters through conditioning on sufficient statistics. This framework allows for any sampling design and is not limited to one level of disease within each set, such as in previous publications. We describe how this ordinal conditional model can be fit using standard conditional logistic regression procedures. We consider an alternative pseudo-likelihood approach that potentially offers robustness under partial model misspecification at the expense of slight loss of efficiency under correct model specification for small sample sizes. We apply our methods to the Massachusetts General Hospital glioblastoma study.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  adjacent categories model; conditional logistic regression; glioblastoma; outcome-based sampling; pseudo-likelihood

Mesh:

Year:  2015        PMID: 25900819      PMCID: PMC4490001          DOI: 10.1002/sim.6503

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  17 in total

1.  Analysis of matched case-control data with multiple ordered disease states: possible choices and comparisons.

Authors:  Bhramar Mukherjee; Ivy Liu; Samiran Sinha
Journal:  Stat Med       Date:  2007-07-30       Impact factor: 2.373

2.  Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma.

Authors:  Eric C Burton; Kathleen R Lamborn; Burt G Feuerstein; Michael Prados; James Scott; Peter Forsyth; Sandra Passe; Robert B Jenkins; Ken D Aldape
Journal:  Cancer Res       Date:  2002-11-01       Impact factor: 12.701

Review 3.  Glioblastoma, cancer stem cells and hypoxia.

Authors:  Eli E Bar
Journal:  Brain Pathol       Date:  2010-11-30       Impact factor: 6.508

4.  Differential retinoic acid signaling in tumors of long- and short-term glioblastoma survivors.

Authors:  Sebastian Barbus; Björn Tews; Daniela Karra; Meinhard Hahn; Bernhard Radlwimmer; Nicolas Delhomme; Christian Hartmann; Jörg Felsberg; Dietmar Krex; Gabriele Schackert; Ramon Martinez; Guido Reifenberger; Peter Lichter
Journal:  J Natl Cancer Inst       Date:  2011-02-23       Impact factor: 13.506

5.  Frequent hypermethylation of the DNA repair gene MGMT in long-term survivors of glioblastoma multiforme.

Authors:  Ramon Martinez; Gabriele Schackert; Ricard Yaya-Tur; Iñigo Rojas-Marcos; James G Herman; Manel Esteller
Journal:  J Neurooncol       Date:  2006-12-13       Impact factor: 4.130

Review 6.  Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization.

Authors:  Rakesh K Jain; Aloke V Finn; Frank D Kolodgie; Herman K Gold; Renu Virmani
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2007-09

7.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

8.  Fitting stratified proportional odds models by amalgamating conditional likelihoods.

Authors:  Bhramar Mukherjee; Jaeil Ahn; Ivy Liu; Paul J Rathouz; Brisa N Sánchez
Journal:  Stat Med       Date:  2008-10-30       Impact factor: 2.373

9.  Long-term survivors of glioblastoma: clinical features and molecular analysis.

Authors:  Yukihiko Sonoda; Toshihiro Kumabe; Mika Watanabe; Yoichi Nakazato; Tomoo Inoue; Masayuki Kanamori; Teiji Tominaga
Journal:  Acta Neurochir (Wien)       Date:  2009-11       Impact factor: 2.216

10.  A polytomous conditional likelihood approach for combining matched and unmatched case-control studies.

Authors:  Mulugeta Gebregziabher; Paulo Guimaraes; Wendy Cozen; David V Conti
Journal:  Stat Med       Date:  2010-01-12       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.